Welcome at the Institute of Clinical Neuroimmunology

Prof. Hohlfeld

Prof. Dr. Hohlfeld

Our institute is devoted to the diagnosis and treatment of neuroimmunological diseases, that is, autoimmune disorders of the nervous system. In autoimmune diseases, the immune system “erroneously” attacks the body´s own tissues. By far the most frequent of these diseases is multiple sclerosis.

The Institute of Clinical Neuroimmunology was founded in 1999. It is the first university institute in Germany focusing on neuroimmunological diseases. [Continue]



Kerschensteiner_Startseite

Prof. Dr. Kerschensteiner


 

Press release

Twin study suggests that human gut bacteria (microbiota) can trigger multiple sclerosis (MS).

12.09.2017 - MS is presumably an autoimmune disorder, but the triggers of the autoimmune reaction have remained unknown. A new study showed that microbiota from MS patients can induce MS-like disease in an animal model. [more...]

 
Proc Natl Acad Sci U S A. 2017 Jul 17. pii: 201701806. doi: 10.1073/pnas.1701806114. [Epub ahead of print]

Visualizing context-dependent calcium signaling in encephalitogenic T cells in vivo by two-photon microscopy

04.08.2017 - Here we visualized intracellular calcium in the encephalitogenic T cells in vivo by using FRET based sensor. The T cells showed short and long lasting calcium signaling dependent on their interaction partners. The blocking of the calcium signaling can be used as target of therapeutic treatments. [more...]

 

Prize for the best PhD thesis of the Medical University Vienna in 2016 for Elisabeth Schuh

06.02.2017 - The prizes for the best PhD thesis and habilitations of the Medical University Vienna in 2016 were awarded during the university lecture of the vfwf. Eligible candidates were able to submit their thesis, which were completed at the Medical University Vienna in 2016. Due to the numerous high-qualit... [more...]

 

Auf der Suche nach neuen Wegen zur Neuroprotektion

01.01.2016 - Klinische Studien mit unerwartetem Ausgang können die Basis für neue Erkenntnisse sein. Obwohl die Depletion von B-Lymphozyten vielversprechend bei der Multiplen Sklerose (MS) ist, führte das Block... [more...]

Engagement für Multiple Sklerose - AMSEL-Stiftungs-Preise 2016 verliehen [Deutsch]

13.10.2016 - Mit Thekla Groll, Sabine Marina und Prof. Dr. Reinhard Hohlfeld zeichnete die AMSEL-Stiftung drei besonders engagierte Menschen aus. Über 200 Gäste kamen zur Feier ins Porsche-Museum. [more...]

DMSG Forschungsprojekte zur Progredienten Multiplen Sklerose

04.12.2016 - Dr. Mehrnoosh Jafari und Prof. Martin Kerschensteiner wollen verstehen, wie es bei der Progredienten Verlaufsform der Multiplen Sklerose zum Nervenzellschaden kommt. Dieses Forschungsvorhaben wird j... [more...]